Insights on Pharmaceuticals & Medical Products

Article

Digital therapeutics: Preparing for takeoff

– Understanding the obstacles to the adoption of digital therapeutics is key to understanding how they might be overcome.
Interview

What’s next for Japan’s pharma market

– The president of Merck in Japan discusses how healthcare players in the country can capitalize on early detection rates and use... collaboration to drive innovation.
Interactive - McKinsey Quarterly

Five Fifty: Synthetic biology

– What do you get when you combine genetic engineering with big data analytics? A new technology for disruptive innovation.
Article

Pursuing breakthroughs in cancer-drug development

– Here’s how to get the right medicines to the right patients faster.
Article

Delivering growth: M&A in medical technology

– Medical-technology companies continue to rely on M&A for growth. How solid is your approach?

Special Collections

Biopharma Frontiers:
What the future holds for the industry

Industry leaders and key stakeholders offer perspectives to inspire discussion and constructive debate.

The pharma launchpad

Ideas for pharma and biotech looking to invest for launch success.

Spotlight on Japan

As the world’s second-largest pharma and medtech market, Japan has historically been an innovation center for the industry.... But amid an evolving healthcare landscape, this collection of articles and interviews looks at what opportunities and challenges executives at life-sciences companies need to address.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights

Article

The evolving role of medical affairs in Asia−Pacific: Three imperatives for pharmacos

– Medical affairs is poised for a broader, more strategic role. However, leaders will need to ramp up new types of capabilities... and talent to achieve this ambition.
Interview

From semiconductors to life sciences: Building a global business out of Japan

– The president and CEO of JSR Corporation discusses the company’s plans to grow a global healthcare franchise building from... his lessons in the semiconductor industry.
Article

The digital imperative for pharma companies in Japan

– Five facts showing that companies should invest in digital customer engagement in Japan.
Interview

The changing face of medical-device design

– Design can help craft a standout patient experience. Here, three leaders discuss how the discipline is improving medical products... and driving innovation.
Interview

Exploring the potential of digital therapeutics

– Three European digital-health CEOs share their perspective on digital therapeutics.
Article

How pharma can accelerate business impact from advanced analytics

– Savvy pharma companies follow these five principles to scale analytics and improve their bottom line.
Article

Digital in R&D: The $100 billion opportunity

– Digital promises to transform R&D productivity over the next decade. What will it take to realize this potential?
Article

The medtech opportunity for Japanese companies

– A large-scale commitment to growth in healthcare technologies could be a key contributor to the Japanese economy.
Article

How medical-device CEOs can navigate digital disruption in healthcare

– Medical-device companies will need to reinvent themselves to stay competitive. Now’s the time to craft a strategy and scale... a transformation.
Commentary

Innovating at the speed of the 21st century in pharmaceuticals

– The CEO of Eli Lilly offers perspectives on accelerating change in the industry.
Article

Elevating the impact of medical affairs in Japan

– Recent research sheds light on the value of the medical channel and what it takes to have a high-performing medical-affairs organization.

Connect with our Pharmaceuticals & Medical Products Practice